Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ultrient is a brand of high-bioavailability dietary supplements that utilizes liposomal delivery technology to enhance the absorption of nutrients such as glutathione and vitamin C. The liposomal formulation encapsulates the active ingredients in lipid vesicles, protecting them from degradation in the gastrointestinal tract and facilitating direct uptake into the systemic circulation. Glutathione, the flagship component, serves as a critical endogenous antioxidant that neutralizes reactive oxygen species (ROS) and acts as a cofactor for enzymes like glutathione peroxidase. By mitigating oxidative stress and supporting hepatic detoxification, Ultrient is intended to promote cellular health and immune function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ultrient.